16-84179200-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001243156.2(TAF1C):āc.2273A>Gā(p.Asp758Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000029 in 1,587,996 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001243156.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAF1C | NM_001243156.2 | c.2273A>G | p.Asp758Gly | missense_variant | 15/15 | ENST00000566732.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAF1C | ENST00000566732.6 | c.2273A>G | p.Asp758Gly | missense_variant | 15/15 | 2 | NM_001243156.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152146Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000143 AC: 3AN: 210086Hom.: 0 AF XY: 0.00000872 AC XY: 1AN XY: 114688
GnomAD4 exome AF: 0.0000237 AC: 34AN: 1435732Hom.: 1 Cov.: 84 AF XY: 0.0000210 AC XY: 15AN XY: 713474
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152264Hom.: 0 Cov.: 34 AF XY: 0.0000940 AC XY: 7AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2022 | The c.2351A>G (p.D784G) alteration is located in exon 14 (coding exon 13) of the TAF1C gene. This alteration results from a A to G substitution at nucleotide position 2351, causing the aspartic acid (D) at amino acid position 784 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at